ConductScience.org, home

Paper7304700

Monitoring compliance with pilocarpine therapy.

Norell SE. Am J Ophthalmol, 1981. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. Monitoring compliance with pilocarpine therapy. Papers, record 7304700. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7304700

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Monitoring compliance with pilocarpine therapy.
PubMed
Journal
Am J Ophthalmol
PubMed
Year
1981
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
3.71
iCite
Revised in PubMed
2019-06-27
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Norell SES E

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlaucomaMajor topic
Patient ComplianceMajor topic
PilocarpineMajor topic
Self AdministrationMajor topic
Aged
Female
Humans
Male
Methods
Middle Aged
Time Factors

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
37311908Adherence and Persistence to Medical Therapy in Glaucoma: An Overview.Ophthalmol Ther2023https://conductscience.org/library/papers/37311908PubMed
30138717Deception in clinical trials and its impact on recruitment and adherence of study participants.Contemp Clin Trials2018https://conductscience.org/library/papers/30138717PubMed
26811672Factors contributing to nonadherence to follow-up appointments in a resident glaucoma clinic versus primary eye care clinic.Patient Prefer Adherence2016https://conductscience.org/library/papers/26811672PubMed
22003282Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review.Patient Prefer Adherence2011https://conductscience.org/library/papers/22003282PubMed
19277229
The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies.
Trans Am Ophthalmol Soc2008https://conductscience.org/library/papers/19277229PubMed
16003515Comparison of carteolol plasmatic levels after repeated instillations of long-acting and regular formulations of carteolol 2% in glaucoma patients.Graefes Arch Clin Exp Ophthalmol2005https://conductscience.org/library/papers/16003515PubMed
8484454Treatment for glaucoma: adherence by the elderly.Am J Public Health1993https://conductscience.org/library/papers/8484454PubMed
8276043Actual versus prescribed timing of lovastatin doses assessed by electronic compliance monitoring.Eur J Clin Pharmacol1993https://conductscience.org/library/papers/8276043PubMed
7093186Glaucoma patients not compliant with their drug therapy: clinical and behavioural aspects.Br J Ophthalmol1982https://conductscience.org/library/papers/7093186PubMed
6848134Compliance with treatment of patients with chronic open-angle glaucoma.Br J Ophthalmol1983https://conductscience.org/library/papers/6848134PubMed
6830740Visual field survival: the response to timolol therapy in open-angle glaucoma.Br J Ophthalmol1983https://conductscience.org/library/papers/6830740PubMed
6123368Beta-blockers in the treatment of chronic simple glaucoma.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6123368PubMed
2576225Efficacy and safety of the combination therapy Pilogel/beta-blocker: interim results.Doc Ophthalmol1989https://conductscience.org/library/papers/2576225PubMed
2373129Dynamics of drug regimen compliance--its assessment by microprocessor-based monitoring.Eur J Clin Pharmacol1990https://conductscience.org/library/papers/2373129PubMed
1680831Long-term treatment with Pilogel/beta-blocker in glaucoma patients.Int Ophthalmol1991https://conductscience.org/library/papers/1680831PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7304700

GET https://conductscience.org/api/papers/v1/7304700/authors